Oleandrin inhibits osteoclast differentiation by targeting the LRP4/MAPK/NF-κB signalling pathway to treat osteoporosis

作者：Chongxin Xiang, Jiankang Cao, Rui Hu, Kaixuan Li, Tingyu Meng, Yutao Xia, Qunbo Meng, Kaiwen Liu, Rui Li, Xuetao Zhu · 发表于：International Immunopharmacology · 年份：2025 · DOI：10.1016/j.intimp.2025.114073 · 被引用次数：6 · 研究领域：Bone Metabolism and Diseases、S100 Proteins and Annexins、GDF15 and Related Biomarkers